Login to Your Account



Experts Debate FDA's Strategy for Monitoring Medical Products

By Donna Young


Monday, June 16, 2008
WASHINGTON - As the FDA sets out to implement its congressional mandate to develop a national active surveillance network for monitoring medical products, the agency must first and foremost ensure that the privacy of patients is not breached, health policy experts said. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription